Long-term outcomes of juvenile-onset mycosis fungoides and lymphomatoid papulosis
Long-term Outcomes Associated With Juvenile-onset Mycosis Fungoides and Lymphomatoid Papulosis
This study is looking at the long-term health of young people diagnosed with juvenile-onset mycosis fungoides and lymphomatoid papulosis to see how they are doing years later.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 100 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | M.D. Anderson Cancer Center Academic / other |
| Locations | 1 site (Houston, Texas) |
| Trial ID | NCT06207812 on ClinicalTrials.gov |
What this trial studies
This observational study aims to follow up with participants diagnosed with juvenile-onset mycosis fungoides (jMF) and lymphomatoid papulosis (lyp) to assess their long-term health outcomes. The primary objective is to evaluate metrics such as overall survival rates over 5 and 10 years, as well as overall disease activity. Additionally, the study will gather information on treatments received and any associated comorbidities. Participants will include those diagnosed before the age of 20, with parents providing information for those under 18.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals diagnosed with juvenile-onset mycosis fungoides or lymphomatoid papulosis before the age of 20.
Not a fit: Patients diagnosed with these conditions after the age of 20 will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into the long-term management and outcomes of juvenile-onset skin lymphomas.
How similar studies have performed: While there may be studies on adult-onset mycosis fungoides, this specific focus on juvenile-onset cases is relatively novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: -To be eligible, participants had to be diagnosed with jMF or lyp before age 20. In the case of participants below the age of 18, parents and not the children will be contacted for participation (children are exempt from participation as their parents may answer our study questions). Exclusion Criteria: -Participants older than 20 years of age at diagnosis
Where this trial is running
Houston, Texas
- MD Anderson Cancer Center — Houston, Texas, United States (Recruiting)
Study contacts
- Principal investigator: Julia Dai, MD — M.D. Anderson Cancer Center
- Study coordinator: Julia Dai, MD
- Email: jdai6@mdanderson.org
- Phone: (713) 515-7961
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.